NICE guidance on obesity and weight management recognises that sustained weight loss of 10% or more can significantly reduce the risk of type 2 diabetes, cardiovascular disease, and musculoskeletal problems
High treatment adherence among elderly patients, together with continuous innovation by domestic pharmaceutical companies and strong academic-industry collaboration, continues to strengthen GLP-1 receptor agonist utilization across the country
Drop a comment: Would you want this as a primary therapy, or would you want to stack it with a GLP-1 if insurance allowed it
The supplement does not contain any GLP-1 receptor agonists or synthetic hormones, which sets it apart from other products on the market
However, researchers in the US said the evidence remains limited and mixed
That matters because a weekly milligram amount, a starting dose, a maintenance target, and an mL injection volume can mean very different things